Difficult-to-heal venous leg ulcers research hub

A multi-centre, randomised, single-blind Phase I/IIa study to evaluate the safety, tolerability and efficacy of a single topical dose of allogeneic integrin α10β1-selected mesenchymal stem cells (XSTEM-VLU) in patients with difficult-to-heal venous leg ulcers

This study is looking at a new treatment for leg ulcers that are hard to heal. It's testing a special patch with cells on it to see if it's safe and helps ulcers get better. This is an early study to learn more about this treatment.